×

Before you go!

Sign up for the FREE weekly email newsletter from the publishers of American Nurse Today. You’ll get breaking news features, exclusive investigative stories, and more — delivered to your inbox.

Sign up today!

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Endocrine

March 2014 Vol. 9 No. 3

Author: Cathy Catrambone, PhD, RN, FAAN; and Rachel Start, MSN, RN

According to a study in Psychoneuroendocrinology, a positive self-esteem can buffer adults older than 60 years against health threats. Researchers found that if an individual’s self-esteem decreased, cortisol levels increased, and vice versa. This association was particularly strong for participants who already had a history of stress . . .

December 2013 Vol. 8 No. 12

Author: Nancy Duffy, DNP, RN, CEN, CNE, and Shannon Bright Smith, DNP, RN, ACNS-BC, CGRN

On Dec. 18, the U.S. Food and Drug Administration (FDA) allowed marketing of the AXIOS Stent and Delivery System for treating pseudocysts that form in the pancreas and are next to the stomach or small intestine. This is the first stent that is specifically designed for drainage of a . . .

October 2013 Vol. 8 No. 10

Author: Nanette Yragui, PhD; Barbara Silverstein, MSN, RN, PhD, MPH; and Whitney Johnson, MPH

Diuretics, angiotensin-1 receptor blockers, and angiotensin-converting enzyme inhibitors seemed to reduce the risk of Alzheimer disease (AD), according to a study, published in Neurology, of adults at least 75 years old who had normal cognition. Diuretics reduced the risk of AD in patients with mild cognitive impairment. Read . . .

October 2013 Vol. 8 No. 10

Author: Nanette Yragui, PhD; Barbara Silverstein, MSN, RN, PhD, MPH; and Whitney Johnson, MPH

Even for people who don’t have diabetes, those who have higher glucose levels are more likely to have memory problems, according to a study published by Neurology. The study included 141 people with an average age of 63 who did not have diabetes or pre-diabetes. Read more and . . .

October 2013 Vol. 8 No. 10

Author: Nanette Yragui, PhD; Barbara Silverstein, MSN, RN, PhD, MPH; and Whitney Johnson, MPH

A systematic review published in Diabetes Care reports that that people taking antidepressants are at a higher risk of type 2 diabetes, although it’s not certain whether the medication is responsible. Read more and read the abstract . . .

Author: Deborah L. Krueger, MSN, RN, NE-BC, CNRN, CHTP

The U.S. Food and Drug Administration (FDA) recently issued warning letters to 15 companies, notifying them the sale of their illegally marketed diabetes products violates federal law. The action is intended to o remove from the market illegal products, including some labeled as dietary supplements, that claim to mitigate . . .

April 2013 Vol. 8 No. 4

Author: Sheyla Desir MSN, RN, CMSRN; Roseanne Fairchild PhD, RN, CNE, NE-BC

On March 29, the U.S. Food and Drug Administration (FDA) approved Invokana (canagliflozin) tablets to treat adults with type 2 diabetes. Invokana has been studied as a stand-alone therapy and in combination with other type 2 diabetes therapies including metformin, sulfonylurea, pioglitazone, and insulin. Read more . . .

February 2013 Vol. 8 No. 2

Author: Lynne Hancock RN, MSN. NE-BC, and Diane Hanley MS, RN-BC, EJD

On Jan. 25, 2013, the U.S. Food and Drug Administration (FDA) approved three new related products for the treatment of type 2 diabetes: Nesina (alogliptin) tablets, Kazano (alogliptin and metformin hydrochloride) tablets, and Oseni (alogliptin and pioglitazone) tablets. Read more . . .

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing